Company Filing History:
Years Active: 2010-2013
Title: Innovations of Kathleen Panter in Cancer Treatment
Introduction
Kathleen Panter is a notable inventor based in Cambridge, MA (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of pharmaceutical compounds. With a total of 3 patents to her name, her work focuses on the modulation of PI3 kinase, a critical pathway in cancer biology.
Latest Patents
One of her latest patents is titled "Inhibitors of PI3 kinase." This invention relates to compounds of Formula (I), or a pharmaceutically acceptable salt thereof, and methods of treating diseases or conditions, such as cancer, using these compounds. The patent also includes pharmaceutical compositions containing the compounds, wherein Q, X, R, and Z are defined within the document.
Another significant patent is "Benzothiazole PI3 kinase modulators for cancer treatment." This invention comprises a new class of compounds capable of modulating the activity of PI3 kinase, making them useful for treating PI3 kinase-mediated diseases, including melanomas, carcinomas, and other cancer-related conditions. The compounds have a general Formula I, with each of A, X, R, and other variables defined in the patent. This invention also includes pharmaceutical compositions, methods for treatment, and processes for preparing the compounds.
Career Highlights
Kathleen Panter is currently associated with Amgen Inc., a leading biotechnology company. Her work at Amgen focuses on developing innovative therapies that target critical pathways in cancer treatment. Her contributions have been instrumental in advancing the understanding and treatment of various cancer types.
Collaborations
Some of her notable coworkers include Laurie B Schenkel and Shon Booker, who collaborate with her on various research projects aimed at improving cancer therapies.
Conclusion
Kathleen Panter's innovative work in the field of cancer treatment through her patents on PI3 kinase modulators highlights her significant impact on medical research. Her contributions continue to pave the way for new therapeutic options in oncology.